Tel Aviv and Boston-based Alpha Tau Medical, a developer of alpha radiation cancer therapy, has secured $29 million in financing. Shavit Capital led the round with participation from other investors that included OurCrowd.com, Medison Ventures and the venture capital arm of Medison Pharma.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: